|
Volumn 5, Issue 1, 2005, Pages 1-3
|
Introduction: Strategies, molecular targets and animal models useful for developing therapies for Alzheimer's disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMYLOID BETA PROTEIN;
ANTIINFLAMMATORY AGENT;
ANTIOXIDANT;
BIOLOGICAL MARKER;
BRAIN PROTEIN;
CASPASE;
CASPASE INHIBITOR;
CHOLINESTERASE INHIBITOR;
DNA;
ENZYME ACTIVATOR;
GINKGO BILOBA EXTRACT;
LIGAND;
NERVE GROWTH FACTOR;
NERVE GROWTH FACTOR RECEPTOR;
NEUROTROPHIC FACTOR;
NEUROTROPHIN RECEPTOR;
PLACEBO;
POLYPEPTIDE;
PROTEIN INHIBITOR;
PROTEIN P75;
PROTEIN TYROSINE KINASE A;
PROTEIN TYROSINE KINASE A AGONIST;
RNA;
UNCLASSIFIED DRUG;
ALZHEIMER DISEASE;
ANTIOXIDANT ACTIVITY;
APOPTOSIS;
BACKACHE;
BIOACCUMULATION;
BRAIN ATROPHY;
BRAIN BLOOD FLOW;
BRAIN CORTEX;
BRAIN METABOLISM;
BRAIN NERVE CELL;
CELL SURVIVAL;
CLINICAL TRIAL;
COGNITIVE DEFECT;
DIAGNOSTIC TEST;
DISEASE COURSE;
DISEASE MARKER;
DISEASE SEVERITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG TARGETING;
EDITORIAL;
EXPERIMENTAL MODEL;
FOREBRAIN;
GLUCOSE METABOLISM;
HIPPOCAMPUS;
HUMAN;
LIFESTYLE;
LIPID PEROXIDATION;
MEMORY;
NERVE CELL LESION;
NERVE CELL NECROSIS;
NERVE DEGENERATION;
NEUROIMAGING;
NEUROPROTECTION;
NONHUMAN;
OXIDATIVE STRESS;
PATHOPHYSIOLOGY;
PATIENT EDUCATION;
PLEIOTROPY;
POSITRON EMISSION TOMOGRAPHY;
PROGNOSIS;
PROTEIN AGGREGATION;
PROTEIN EXPRESSION;
SIDE EFFECT;
TECHNIQUE;
WEIGHT REDUCTION;
|
EID: 15344339239
PISSN: 15680150
EISSN: None
Source Type: Journal
DOI: 10.2174/1568015053202778 Document Type: Editorial |
Times cited : (2)
|
References (22)
|